Integrated immune-related gene signature predicts clinical outcome for patients with Luminal B breast cancer

Zhen Xie(Sun Yat-sen University), Xiaying Kuang(Sun Yat-sen University), Ying Lin(Sun Yat-sen University), Du Cai(Southern Medical University), Nan Shao(Sun Yat-sen University), Zhen Shan(Shenyang Medical College), Feng Gao(Henan Provincial People's Hospital), Runyi Ye(Sun Yat-sen University)
Research Square
August 1, 2022
10.21203/rs.3.rs-1740378/v1
Cited by 0

Related Papers

Effect of Capecitabine Maintenance Therapy Using Lower Dosage and Higher Frequency vs Observation on Disease-Free Survival Among Patients With Early-Stage Triple-Negative Breast Cancer Who Had Received Standard Treatment
|JAMA|2020|229
Hyaluronan oligosaccharides are potential stimulators to angiogenesis via RHAMM mediated signal pathway in wound healing
|Clinical and investigative medicine|2008|148
Overexpression of kinesin superfamily members as prognostic biomarkers of breast cancer
|Cancer Cell International|2020|136
An Endocrine Genetic Signal Between Blood Cells and Vascular Smooth Muscle Cells
|Journal of the American College of Cardiology|2015|126
Toripalimab plus nab-paclitaxel in metastatic or recurrent triple-negative breast cancer: a randomized phase 3 trial
|Nature Medicine|2024|121